No Data
No Data
Express News | Lyra Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "SCAFFOLD LOADING AND DELIVERY SYSTEMS (FOR TUBULAR IMPLANTS)"
Motive Partners and Apollo Launch Lyra Client Solutions
Lyra Therapeutics Pursues ENLIGHTEN 2 Trial for LYR-210
Lyra Therapeutics (LYRA) Upgraded to Strong Buy: Here's What You Should Know
Michael Altman and Konstantin Poukalov Resign From Lyra Therapeutics Board
Lyra Health Welcomes Jennifer Schulz as Chief Executive Officer
Unlock the Full List